Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3020

Actual shortage: 235 (8%)
Anticipated shortage: 19 (1%)
Avoided shortage: 9 (0%)
Resolved: 2757 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

28 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CIPROFLOX 0.3% SOLUTION Resolved 2017-03-10 2019-06-12 110
APO-OFLOXACIN 0.3% SOLUTION Resolved 2017-03-10 2019-01-08 405
APO-TOBRAMYCIN 0.3% SOLUTION Actual shortage 2017-08-14 2017-10-05 19123
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2023-09-28 2023-11-24 205486
APO-GATIFLOXACIN 0.3% SOLUTION Resolved 2024-03-27 2024-04-12 223555
APO-NITROGLYCERIN 0.4MG METERED-DOSE PUMP Resolved 2017-03-10 2018-02-26 402
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-05-10 2017-05-13 9946
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-17 2017-10-24 15995
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-07-26 2017-11-13 17331
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-28 2018-01-22 31039
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-01-15 2019-02-21 72363
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-04-24 2019-06-21 82337
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-05-15 2019-06-24 84159
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2019-06-05 2019-06-21 85619
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-02 2021-02-23 123581
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-09-17 2021-02-23 124359
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-07 2021-02-23 125824
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-08-19 2022-10-14 167421
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2022-12-09 2023-02-02 177600
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-06 2023-04-21 188973

Showing 101 to 120 of 3020

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DONEPEZIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60453
APO-ENALAPRIL 5MG TABLET Discontinued 2018-09-07 2018-11-02 60468
APO GLYBURIDE TAB 5MG 5MG TABLET Discontinued 2018-09-07 2018-12-14 60518
APO-LISINOPRIL 5MG TABLET Discontinued 2018-09-07 2019-02-13 60585
APO PREDNISONE TAB 5MG 5MG TABLET Discontinued 2018-09-08 2018-12-28 60699
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
BISACODYL 5MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-03 71090
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-CAPTO TAB 6.25MG 6.25MG TABLET Discontinued 2018-09-07 2019-06-12 60339
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-GEMFIBROZIL 600MG TABLET Discontinued 2017-03-31 2017-03-31 4927
APO-ATOMOXETINE 60MG CAPSULE Discontinued 2018-09-07 2018-09-15 60273
APO-BOSENTAN 62.5MG TABLET Discontinued 2019-01-04 2019-01-04 71339
APO-BROMAZEPAM 6MG TABLET Discontinued 2018-09-07 2018-10-19 60310
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-CIPROFLOX 750MG TABLET Discontinued 2018-09-07 2018-12-28 60388
APO-FENTANYL MATRIX 75MCG PATCH Discontinued 2018-09-07 2018-09-15 60497

Showing 321 to 340 of 356